Administration of dexamethasone induces proteinuria of glomerular origin in mice

Ann Chen, Lai Fa Sheu, Yat Sen Ho, Yu Feng Lin, Wei Yuan Chou, Jia Yi Wang, Wei Hwa Lee

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

The administration of glucocorticoids has been reported to exacerbate proteinuria in a few patients with glomerulonephritis. This effect has not been well recognized, and the pathogenetic mechanism responsible for this phenomenon remains to be clarified. In this study, we observed that a high daily oral dose (0.5 mg/kg body weight) of dexamethasone was capable of inducing overt proteinuria in mice, beginning on day 5 and persisting for a 19-day duration. One fourth of mice also intermittently presented with slight hematuria beginning on day 12. Rental lesions in the dexamethasone-treated mice, which were killed on day 23, were characterized by mild mesangial expansion, segmental or global hyalinosis/sclerosis in deep cortical glomeruli, and focal tubular changes. No glomerular inflammatory cell infiltration or proliferative lesion was noted in any of the mice. Ultrastructural features of glomeruli included mesangial widening characterized by either an increase of mesangial matrix, dilated mesangial channels filled with slightly electron-dense material or mesangial lysis- like appearance showing intracytoplasmic microcysts filled with electron- lucent material, and evidence to support injury of endothelial cells, erythrocytes, and podocytes. An immunofluorescence study revealed enhanced glomerular deposition of IgG, IgA, IgM, and fibrinogen (P <0.001, compared with normal control mice), but no glomerular C3 deposition was identified in any of the dexamethasone-treated mice. Charge analysis showed no impairment in anionic property of glomerular tufts in the dexamethasone-treated mice. In addition, the dexamethasone-induced proteinuria was greatly attenuated by treatment with a low molecular weight heparin, although it was not reduced by an angiotensin-converting enzyme inhibitor. Data from these experiments suggest that a large dose of glucocorticoids is potentially nephrotoxic. Alteration of a size-dependent permeability may predominantly contribute to the dexamethasone-induced proteinuria. However, the effect of glomerular hyperfiltration may be only partially involved in the pathogenesis of this dexamethasone-induced glomerulopathy in mice.

Original languageEnglish
Pages (from-to)443-452
Number of pages10
JournalAmerican Journal of Kidney Diseases
Volume31
Issue number3
Publication statusPublished - Mar 1998
Externally publishedYes

Fingerprint

Proteinuria
Dexamethasone
Glucocorticoids
Electrons
Podocytes
Low Molecular Weight Heparin
Sclerosis
Hematuria
Glomerulonephritis
Angiotensin-Converting Enzyme Inhibitors
Fibrinogen
Immunoglobulin A
Fluorescent Antibody Technique
Immunoglobulin M
Permeability
Endothelial Cells
Immunoglobulin G
Erythrocytes
Body Weight
Wounds and Injuries

Keywords

  • Dexamthasone
  • Fibrinogen
  • Glomerulosclerosis
  • Heparin
  • Hyperfiltration
  • Nephrotoxi city
  • Proteinuria

ASJC Scopus subject areas

  • Nephrology

Cite this

Administration of dexamethasone induces proteinuria of glomerular origin in mice. / Chen, Ann; Sheu, Lai Fa; Ho, Yat Sen; Lin, Yu Feng; Chou, Wei Yuan; Wang, Jia Yi; Lee, Wei Hwa.

In: American Journal of Kidney Diseases, Vol. 31, No. 3, 03.1998, p. 443-452.

Research output: Contribution to journalArticle

@article{635fcef351044e738816ee4061a5e4e9,
title = "Administration of dexamethasone induces proteinuria of glomerular origin in mice",
abstract = "The administration of glucocorticoids has been reported to exacerbate proteinuria in a few patients with glomerulonephritis. This effect has not been well recognized, and the pathogenetic mechanism responsible for this phenomenon remains to be clarified. In this study, we observed that a high daily oral dose (0.5 mg/kg body weight) of dexamethasone was capable of inducing overt proteinuria in mice, beginning on day 5 and persisting for a 19-day duration. One fourth of mice also intermittently presented with slight hematuria beginning on day 12. Rental lesions in the dexamethasone-treated mice, which were killed on day 23, were characterized by mild mesangial expansion, segmental or global hyalinosis/sclerosis in deep cortical glomeruli, and focal tubular changes. No glomerular inflammatory cell infiltration or proliferative lesion was noted in any of the mice. Ultrastructural features of glomeruli included mesangial widening characterized by either an increase of mesangial matrix, dilated mesangial channels filled with slightly electron-dense material or mesangial lysis- like appearance showing intracytoplasmic microcysts filled with electron- lucent material, and evidence to support injury of endothelial cells, erythrocytes, and podocytes. An immunofluorescence study revealed enhanced glomerular deposition of IgG, IgA, IgM, and fibrinogen (P <0.001, compared with normal control mice), but no glomerular C3 deposition was identified in any of the dexamethasone-treated mice. Charge analysis showed no impairment in anionic property of glomerular tufts in the dexamethasone-treated mice. In addition, the dexamethasone-induced proteinuria was greatly attenuated by treatment with a low molecular weight heparin, although it was not reduced by an angiotensin-converting enzyme inhibitor. Data from these experiments suggest that a large dose of glucocorticoids is potentially nephrotoxic. Alteration of a size-dependent permeability may predominantly contribute to the dexamethasone-induced proteinuria. However, the effect of glomerular hyperfiltration may be only partially involved in the pathogenesis of this dexamethasone-induced glomerulopathy in mice.",
keywords = "Dexamthasone, Fibrinogen, Glomerulosclerosis, Heparin, Hyperfiltration, Nephrotoxi city, Proteinuria",
author = "Ann Chen and Sheu, {Lai Fa} and Ho, {Yat Sen} and Lin, {Yu Feng} and Chou, {Wei Yuan} and Wang, {Jia Yi} and Lee, {Wei Hwa}",
year = "1998",
month = "3",
language = "English",
volume = "31",
pages = "443--452",
journal = "American Journal of Kidney Diseases",
issn = "0272-6386",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Administration of dexamethasone induces proteinuria of glomerular origin in mice

AU - Chen, Ann

AU - Sheu, Lai Fa

AU - Ho, Yat Sen

AU - Lin, Yu Feng

AU - Chou, Wei Yuan

AU - Wang, Jia Yi

AU - Lee, Wei Hwa

PY - 1998/3

Y1 - 1998/3

N2 - The administration of glucocorticoids has been reported to exacerbate proteinuria in a few patients with glomerulonephritis. This effect has not been well recognized, and the pathogenetic mechanism responsible for this phenomenon remains to be clarified. In this study, we observed that a high daily oral dose (0.5 mg/kg body weight) of dexamethasone was capable of inducing overt proteinuria in mice, beginning on day 5 and persisting for a 19-day duration. One fourth of mice also intermittently presented with slight hematuria beginning on day 12. Rental lesions in the dexamethasone-treated mice, which were killed on day 23, were characterized by mild mesangial expansion, segmental or global hyalinosis/sclerosis in deep cortical glomeruli, and focal tubular changes. No glomerular inflammatory cell infiltration or proliferative lesion was noted in any of the mice. Ultrastructural features of glomeruli included mesangial widening characterized by either an increase of mesangial matrix, dilated mesangial channels filled with slightly electron-dense material or mesangial lysis- like appearance showing intracytoplasmic microcysts filled with electron- lucent material, and evidence to support injury of endothelial cells, erythrocytes, and podocytes. An immunofluorescence study revealed enhanced glomerular deposition of IgG, IgA, IgM, and fibrinogen (P <0.001, compared with normal control mice), but no glomerular C3 deposition was identified in any of the dexamethasone-treated mice. Charge analysis showed no impairment in anionic property of glomerular tufts in the dexamethasone-treated mice. In addition, the dexamethasone-induced proteinuria was greatly attenuated by treatment with a low molecular weight heparin, although it was not reduced by an angiotensin-converting enzyme inhibitor. Data from these experiments suggest that a large dose of glucocorticoids is potentially nephrotoxic. Alteration of a size-dependent permeability may predominantly contribute to the dexamethasone-induced proteinuria. However, the effect of glomerular hyperfiltration may be only partially involved in the pathogenesis of this dexamethasone-induced glomerulopathy in mice.

AB - The administration of glucocorticoids has been reported to exacerbate proteinuria in a few patients with glomerulonephritis. This effect has not been well recognized, and the pathogenetic mechanism responsible for this phenomenon remains to be clarified. In this study, we observed that a high daily oral dose (0.5 mg/kg body weight) of dexamethasone was capable of inducing overt proteinuria in mice, beginning on day 5 and persisting for a 19-day duration. One fourth of mice also intermittently presented with slight hematuria beginning on day 12. Rental lesions in the dexamethasone-treated mice, which were killed on day 23, were characterized by mild mesangial expansion, segmental or global hyalinosis/sclerosis in deep cortical glomeruli, and focal tubular changes. No glomerular inflammatory cell infiltration or proliferative lesion was noted in any of the mice. Ultrastructural features of glomeruli included mesangial widening characterized by either an increase of mesangial matrix, dilated mesangial channels filled with slightly electron-dense material or mesangial lysis- like appearance showing intracytoplasmic microcysts filled with electron- lucent material, and evidence to support injury of endothelial cells, erythrocytes, and podocytes. An immunofluorescence study revealed enhanced glomerular deposition of IgG, IgA, IgM, and fibrinogen (P <0.001, compared with normal control mice), but no glomerular C3 deposition was identified in any of the dexamethasone-treated mice. Charge analysis showed no impairment in anionic property of glomerular tufts in the dexamethasone-treated mice. In addition, the dexamethasone-induced proteinuria was greatly attenuated by treatment with a low molecular weight heparin, although it was not reduced by an angiotensin-converting enzyme inhibitor. Data from these experiments suggest that a large dose of glucocorticoids is potentially nephrotoxic. Alteration of a size-dependent permeability may predominantly contribute to the dexamethasone-induced proteinuria. However, the effect of glomerular hyperfiltration may be only partially involved in the pathogenesis of this dexamethasone-induced glomerulopathy in mice.

KW - Dexamthasone

KW - Fibrinogen

KW - Glomerulosclerosis

KW - Heparin

KW - Hyperfiltration

KW - Nephrotoxi city

KW - Proteinuria

UR - http://www.scopus.com/inward/record.url?scp=0031892423&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031892423&partnerID=8YFLogxK

M3 - Article

C2 - 9506681

AN - SCOPUS:0031892423

VL - 31

SP - 443

EP - 452

JO - American Journal of Kidney Diseases

JF - American Journal of Kidney Diseases

SN - 0272-6386

IS - 3

ER -